202 related articles for article (PubMed ID: 27185624)
1. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
[TBL] [Abstract][Full Text] [Related]
2. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
[TBL] [Abstract][Full Text] [Related]
3.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
4. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
Abed Y; Pizzorno A; Bouhy X; Rhéaume C; Boivin G
J Virol; 2014 Feb; 88(3):1652-8. PubMed ID: 24257597
[TBL] [Abstract][Full Text] [Related]
5. Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.
Abed Y; Tu V; Carbonneau J; Checkmahomed L; Venable MC; Fage C; Marie-Ève-Hamelin ; Dufresne SF; Kobinger G; Boivin G
Antiviral Res; 2018 Nov; 159():26-34. PubMed ID: 30219318
[TBL] [Abstract][Full Text] [Related]
6. The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness.
Tu V; Abed Y; Barbeau X; Carbonneau J; Fage C; Lagüe P; Boivin G
Antiviral Res; 2017 Jan; 137():6-13. PubMed ID: 27838351
[TBL] [Abstract][Full Text] [Related]
7. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
8. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
9. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
Abed Y; Pizzorno A; Bouhy X; Boivin G
Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
[TBL] [Abstract][Full Text] [Related]
10. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
[TBL] [Abstract][Full Text] [Related]
11. Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
Tu V; Abed Y; Fage C; Baz M; Boivin G
Antiviral Res; 2018 Jun; 154():110-115. PubMed ID: 29674164
[TBL] [Abstract][Full Text] [Related]
12. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
[TBL] [Abstract][Full Text] [Related]
13. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
[TBL] [Abstract][Full Text] [Related]
15. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
16. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
Butler J; Hooper KA; Petrie S; Lee R; Maurer-Stroh S; Reh L; Guarnaccia T; Baas C; Xue L; Vitesnik S; Leang SK; McVernon J; Kelso A; Barr IG; McCaw JM; Bloom JD; Hurt AC
PLoS Pathog; 2014 Apr; 10(4):e1004065. PubMed ID: 24699865
[TBL] [Abstract][Full Text] [Related]
17. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
[TBL] [Abstract][Full Text] [Related]
18. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
[TBL] [Abstract][Full Text] [Related]
19. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
[TBL] [Abstract][Full Text] [Related]
20. Droplet digital PCR to investigate quasi-species at codons 119 and 275 of the A(H1N1)pdm09 neuraminidase during zanamivir and oseltamivir therapies.
Abed Y; Carbonneau J; L'Huillier AG; Kaiser L; Boivin G
J Med Virol; 2017 Apr; 89(4):737-741. PubMed ID: 27602879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
